Skip to main content
Journal cover image

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Publication ,  Journal Article
Fernández, J; Clària, J; Amorós, A; Aguilar, F; Castro, M; Casulleras, M; Acevedo, J; Duran-Güell, M; Nuñez, L; Costa, M; Torres, M; Prado, V ...
Published in: Gastroenterology
July 2019

We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia, cardiocirculatory dysfunction, portal hypertension, and systemic inflammation in patients with decompensated cirrhosis with and without bacterial infections.We performed a prospective study to assess the effects of long-term (12 weeks) treatment with low doses (1 g/kg body weight every 2 weeks) and high doses (1.5 g/kg every week) of albumin on serum albumin, plasma renin, cardiocirculatory function, portal pressure, and plasma levels of cytokines, collecting data from 18 patients without bacterial infections (the Pilot-PRECIOSA study). We also assessed the effect of short-term (1 week) treatment with antibiotics alone vs the combination of albumin plus antibiotics (1.5 g/kg on day 1 and 1 g/kg on day 3) on plasma levels of cytokines in biobanked samples from 78 patients with bacterial infections included in a randomized controlled trial (INFECIR-2 study).Circulatory dysfunction and systemic inflammation were extremely unstable in many patients included in the Pilot-PRECIOSA study; these patients had intense and reversible peaks in plasma levels of renin and interleukin 6. Long-term high-dose albumin, but not low-dose albumin, was associated with normalization of serum level of albumin, improved stability of the circulation and left ventricular function, and reduced plasma levels of cytokines (interleukin 6, granulocyte colony-stimulating factor, interleukin 1 receptor antagonist, and vascular endothelial growth factor) without significant changes in portal pressure. The immune-modulatory effects of albumin observed in the Pilot-PRECIOSA study were confirmed in the INFECIR-2 study. In this study, patients given albumin had significant reductions in plasma levels of cytokines.In an analysis of data from 2 trials (Pilot-PRECIOSA study and INFECIR-2 study), we found that albumin treatment reduced systemic inflammation and cardiocirculatory dysfunction in patients with decompensated cirrhosis. These effects might be responsible for the beneficial effects of albumin therapy on outcomes of patients with decompensated cirrhosis. ClinicalTrials.gov, Numbers: NCT00968695 and NCT03451292.

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gastroenterology

DOI

EISSN

1528-0012

ISSN

0016-5085

Publication Date

July 2019

Volume

157

Issue

1

Start / End Page

149 / 162

Related Subject Headings

  • Serum Albumin
  • Renin
  • Prospective Studies
  • Portal System
  • Portal Pressure
  • Middle Aged
  • Male
  • Liver Cirrhosis
  • Liver Circulation
  • Inflammation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fernández, J., Clària, J., Amorós, A., Aguilar, F., Castro, M., Casulleras, M., … Arroyo, V. (2019). Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. Gastroenterology, 157(1), 149–162. https://doi.org/10.1053/j.gastro.2019.03.021
Fernández, Javier, Joan Clària, Alex Amorós, Ferrán Aguilar, Miriam Castro, Mireia Casulleras, Juan Acevedo, et al. “Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.Gastroenterology 157, no. 1 (July 2019): 149–62. https://doi.org/10.1053/j.gastro.2019.03.021.
Fernández J, Clària J, Amorós A, Aguilar F, Castro M, Casulleras M, et al. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. Gastroenterology. 2019 Jul;157(1):149–62.
Fernández, Javier, et al. “Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.Gastroenterology, vol. 157, no. 1, July 2019, pp. 149–62. Epmc, doi:10.1053/j.gastro.2019.03.021.
Fernández J, Clària J, Amorós A, Aguilar F, Castro M, Casulleras M, Acevedo J, Duran-Güell M, Nuñez L, Costa M, Torres M, Horrillo R, Ruiz-Del-Árbol L, Villanueva C, Prado V, Arteaga M, Trebicka J, Angeli P, Merli M, Alessandria C, Aagaard NK, Soriano G, Durand F, Gerbes A, Gustot T, Welzel TM, Salerno F, Bañares R, Vargas V, Albillos A, Silva A, Morales-Ruiz M, Carlos García-Pagán J, Pavesi M, Jalan R, Bernardi M, Moreau R, Páez A, Arroyo V. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. Gastroenterology. 2019 Jul;157(1):149–162.
Journal cover image

Published In

Gastroenterology

DOI

EISSN

1528-0012

ISSN

0016-5085

Publication Date

July 2019

Volume

157

Issue

1

Start / End Page

149 / 162

Related Subject Headings

  • Serum Albumin
  • Renin
  • Prospective Studies
  • Portal System
  • Portal Pressure
  • Middle Aged
  • Male
  • Liver Cirrhosis
  • Liver Circulation
  • Inflammation